|
시장보고서
상품코드
2055290
Drug Discovery 플랫폼 시장 : 약제 유형별, 기술별, 치료 영역별, 용도별, 최종사용자별, 지역별Drug Discovery Platforms Market, By Drug Type, By Technology, By Therapeutic Area, By Application, By End User, By Geography |
||||||
Drug Discovery 플랫폼 시장은 2026년 2억 4,020만 달러로 추정되며, 2033년까지 5억 9,020만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 13.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 2억 4,020만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 13.70% | 2033년 시장 규모 예측 : | 5억 9,020만 달러 |
세계 신약 개발 플랫폼 시장은 신규 치료제에 대한 수요 증가와 보다 효율적인 신약 개발 프로세스에 대한 필요성에 힘입어 최근 몇 년간 눈부신 성장을 이루고 있습니다. 신약 개발 플랫폼은 고처리량 스크리닝, 유전체학, 단백질체학, 계산 도구 등의 첨단 기술을 활용하여 신규 후보 약물의 발굴 및 개발 과정에서 매우 중요한 역할을 수행하고 있습니다. 이러한 플랫폼을 통해 연구자들은 신약 개발 과정을 효율화하고, 비용을 절감하며, 초기 스크리닝부터 임상시험까지의 기간을 단축할 수 있게 됩니다. 이 시장에는 생화학적 분석, 세포 기반 분석, 인실리코 모델링, 단편 기반 신약 개발 등 다양한 유형의 플랫폼이 포함됩니다. 만성 질환 증가, 맞춤형 의료의 부상, 제약 기업과 학술 기관 간의 협력 강화로 인해 신약 개발 플랫폼의 도입이 더욱 가속화되고 있습니다.
시장 역학:
세계 신약 개발 플랫폼 시장은 만성 질환 유병률 증가, 맞춤형 의료에 대한 수요 증가, 보다 효율적인 신약 개발 프로세스의 필요성 등 여러 요인에 힘입어 성장하고 있습니다. 암, 심혈관 질환, 신경계 질환의 유병률 증가는 신약에 대한 막대한 수요를 창출하며, 신약 개발 플랫폼 시장의 성장을 견인하고 있습니다. 또한, 맞춤형 의료로의 전환에 따라 표적 치료제 개발이 요구되고 있으며, 이를 위해서는 특정 분자 표적을 규명하고 신약 후보 물질을 최적화하기 위한 신약 개발 플랫폼이 필수적입니다. 그러나 신약 개발 및 상업화에 수반되는 높은 비용과 의약품 승인을 위한 엄격한 규제 요건이 시장 성장을 저해하고 있습니다. 또한, 숙련된 전문 인력의 부족과 다양한 기술을 통합할 때 발생하는 복잡성도 시장 성장에 있어 과제로 대두되고 있습니다. 이러한 제약이 있음에도 불구하고, 이 시장에는 신약 개발에 인공지능(AI)과 머신러닝의 도입 확대, 희귀질환에 대한 관심 증가, 그리고 혁신적인 신약 개발 솔루션을 개발하기 위한 제약사와 기술 제공업체 간의 협력 가능성 등 큰 기회가 존재합니다.
본 조사의 주요 특징:
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 신약 개발 플랫폼 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 신약 개발 플랫폼 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 신약 개발 플랫폼 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 Drug Discovery 플랫폼 시장 : 약제 유형별, 2021년-2033년
제5장 세계의 Drug Discovery 플랫폼 시장 : 기술별, 2021년-2033년
제6장 세계의 Drug Discovery 플랫폼 시장 : 치료 영역별, 2021년-2033년
제7장 세계의 Drug Discovery 플랫폼 시장 : 용도별, 2021년-2033년
제8장 세계의 Drug Discovery 플랫폼 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 Drug Discovery 플랫폼 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.23Drug Discovery Platforms Market is estimated to be valued at USD 240.2 Mn in 2026 and is expected to reach USD 590.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 240.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.70% | 2033 Value Projection: | USD 590.2 Mn |
The global drug discovery platforms market has witnessed significant growth in recent years, driven by the increasing demand for novel therapeutics and the need for more efficient drug discovery processes. Drug discovery platforms play a crucial role in the identification and development of new drug candidates, utilizing advanced technologies such as high-throughput screening, genomics, proteomics, and computational tools. These platforms enable researchers to streamline the drug discovery process, reduce costs, and accelerate the timeline from initial screening to clinical trials. The market encompasses various types of platforms, including biochemical assays, cell-based assays, in silico modeling, and fragment-based drug discovery. The adoption of drug discovery platforms has been further fueled by the growing prevalence of chronic diseases, the emergence of personalized medicine, and the increasing collaboration between pharmaceutical companies and academic institutions.
Market Dynamics:
The global drug discovery platforms market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for more efficient drug discovery processes. The rising prevalence of cancer, cardiovascular diseases, and neurological disorders has created a significant demand for novel therapeutics, propelling the growth of the drug discovery platforms market. Additionally, the shift towards personalized medicine has necessitated the development of targeted therapies, which rely heavily on drug discovery platforms for identifying specific molecular targets and optimizing drug candidates. However, the market growth is restrained by the high cost associated with drug discovery and development, as well as the stringent regulatory requirements for drug approval. Furthermore, the lack of skilled professionals and the complexity of integrating various technologies pose challenges to market growth. Despite these restraints, the market presents significant opportunities, such as the increasing adoption of artificial intelligence and machine learning in drug discovery, the growing focus on rare diseases, and the potential for collaborations between pharmaceutical companies and technology providers to develop innovative drug discovery solutions.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global drug discovery platforms market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, PerkinElmer, Merck KGaA, Roche Holding AG, QIAGEN, Bruker Corporation, Bio-Rad Laboratories, Illumina, Charles River Laboratories, Evotec, WuXi AppTec, Schrodinger, and Abcam
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global drug discovery platforms market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery platforms market
Market Segmentation
- Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small Molecule
- Large Molecule
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Genomics
- Proteomics
- Cell-Based Assays
- High-Throughput Screening (HTS)
- Bioinformatics
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- Imaging Technologies
- Microfluidics
- Artificial Intelligence (AI) & Machine Learning (ML)
- Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Neurology
- Infectious And Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Testing
- Others (Clinical Trials, etc.)
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Academic and Research Institutes
- CROs/CDMOs
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Agilent Technologies
- Danaher Corporation
- PerkinElmer
- Merck KGaA
- Roche Holding AG
- QIAGEN
- Bruker Corporation
- Bio-Rad Laboratories
- Illumina
- Charles River Laboratories
- Evotec
- WuXi AppTec
- Schrodinger
- Abcam
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Discovery Platforms Market, By Drug Type
- Global Drug Discovery Platforms Market, By Technology
- Global Drug Discovery Platforms Market, By Therapeutic Area
- Global Drug Discovery Platforms Market, By Application
- Global Drug Discovery Platforms Market, By End User
- Global Drug Discovery Platforms Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Discovery Platforms Market, By Drug Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Drug Discovery Platforms Market, By Technology, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cell-Based Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- High-Throughput Screening (HTS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Imaging Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Artificial Intelligence (AI) & Machine Learning (ML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Drug Discovery Platforms Market, By Therapeutic Area, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Infectious And Immune System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Digestive System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Drug Discovery Platforms Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Target Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Target Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Lead Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Lead Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Clinical Trials, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Drug Discovery Platforms Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Drug Discovery Platforms Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
